首页 | 本学科首页   官方微博 | 高级检索  
     

抗氧化剂:治疗甲状腺相关性眼病的新选择
引用本文:何志伟,胡欣,陈国芳,刘超. 抗氧化剂:治疗甲状腺相关性眼病的新选择[J]. 眼科新进展, 2022, 0(5): 417-420. DOI: 10.13389/j.cnki.rao.2022.0085
作者姓名:何志伟  胡欣  陈国芳  刘超
作者单位:210028 江苏省南京市,南京中医药大学附属中西医结合医院(何志伟,胡欣,陈国芳,刘超);210028 江苏省南京市,国家中医药管理局瘿病证治重点研究室(何志伟,陈国芳,刘超)
摘    要:甲状腺相关性眼病(TAO)是一种器官特异性自身免疫性疾病,其发病机制复杂,可引起一系列眼部症状,对患者的生活质量和心理健康造成严重影响。目前针对TAO的各种治疗方式均不尽如人意。鉴于氧化应激与TAO的发病密切相关,且硒作为抗氧化剂可有效改善轻度TAO患者的临床症状和生活质量,故抗氧化治疗成为处理TAO的新选择。体外研究显示,维生素C、N-乙酰-L-半胱氨酸、β-胡萝卜素等抗氧化剂可以减少TAO患者眼眶炎症因子的释放,并抑制成纤维细胞的增殖。此外,一些中药活性成分,如槲皮素、虎杖苷、甲基莲心碱具有抗氧化作用,同样能抑制眼眶成纤维细胞的增殖,提示这些药物或制剂或许可以应用于TAO的临床治疗。

关 键 词:甲状腺相关性眼病  抗氧化剂  氧化应激  活性氧  

Antioxidant: a new therapy for thyroid associated ophthalmopathy
HE Zhiwei,' target=_blank rel=external>,HU Xin,CHEN Guofang,' target=_blank rel=external>,LIU Chao,' target=_blank rel=external>. Antioxidant: a new therapy for thyroid associated ophthalmopathy[J]. Recent Advances in Ophthalmology, 2022, 0(5): 417-420. DOI: 10.13389/j.cnki.rao.2022.0085
Authors:HE Zhiwei  ' target=_blank rel=external>  HU Xin  CHEN Guofang  ' target=_blank rel=external>  LIU Chao  ' target=_blank rel=external>
Affiliation:1.Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,Jiangsu Province,China2.Key Laboratory of TCM Syndrome & Treatment of Yingbing of State Administration of Traditional Chinese Medicine,Nanjing 210028,Jiangsu Province,China
Abstract:Thyroid associated ophthalmopathy (TAO) is an organ-specific autoimmune disease with a complex pathogenesis, which can cause a series of ocular symptoms and seriously affect the quality of life and mental health of patients. The various treatments currently available for TAO are unsatisfactory. Given that oxidative stress is closely associated with the development of TAO and that selenium, as an antioxidant, can effectively improve the clinical symptoms and quality of life of patients with mild TAO, antioxidant therapy is a new option for the treatment of TAO. In vitro studies have shown that antioxidants such as vitamin C, N-acetyl-L-cysteine, and β-carotene can reduce the release of orbital inflammatory cytokines and inhibit the proliferation of fibroblasts in patients with TAO. In addition, some active ingredients of Chinese herbs, such as quercetin, polydatin and neferine, have antioxidant effects and can also inhibit the proliferation of orbital fibroblasts, suggesting that these drugs or preparations may be applied in the clinical treatment of TAO.
Keywords:thyroid associated ophthalmopathy   antioxidant   oxidative stress   reactive oxygen species   selenium
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号